Nosocomial candidemia in adults: Risk and prognostic factors;Candidémie nosocomiale chez des adultes: facteurs de risque et de pronostic

Journal de Mycologie Medicale

Volumn 20, Issue 4, 2010, Pages 269-278

  Gurcuoglu E ^a   Akalin, H ^a   Ener, B ^a   Ocakoglu G ^a   Sinirtas M ^a   Akçaĝlar, Sevim ^a   Yilmaz, E ^a   Evci, C ^a   Oral, B ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Mortality; Nosocomial candidemia; Risk factors

Indexed keywords

ANTACID AGENT; FLUCONAZOLE;

ABDOMINAL SURGERY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDEMIA; CANDIDURIA; CASE CONTROL STUDY; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FUNGUS ISOLATION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; NASOGASTRIC TUBE; NEUTROPENIA; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TOTAL PARENTERAL NUTRITION;

CANDIDA ALBICANS;

EID: 78649915273     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mycmed.2010.07.006     Document Type: Article

References (42)

1. Acar A., Oncül O., Kucukardali Y., Ozyurt M., Haznedaroĝlu T., Çavuşlu Ş. Epidemiological features of Candida infections detected in intensive care units and risk factors affecting mortality. Mikrobiyol Bult 2008, 451-461.
2. Alanso-Valle H., Acha O., Garcio-Palamo J.D., Farinas-Alvarez C., Fernandez-Mazarrasa C., Farinas M.C. Candidemia in tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 2003, 254-257.
3. Almirante B., Rodriguez D., Park B.J., Cuenca-Estrella M., Planes A.M., Almela M., et al. Epidemiology and predictors of mortality in cases of Candida Bloodstream Infections: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005, 1829-1835.
4. Almirante B., Rodriguez D., Cuenca-Estrella M., Almela M., Sanchez F., Ayata J., et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis Bloodstream Infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2006, 1681-1685.
5. Bakir M., Cerikcioglu N., Barton R., Yagci A. Epidemiology of candidemia in a Turkish tertiary care hospital. APMIS 2006, 601-610.
6. Bassetti M., Trecarichi E.M., Sanguinetti M., Bisio F., Posteraro B., Soro O., et al. Incidence, risk factors and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diag Microbiol Infect Dis 2007, 325-331.
7. Blumberg H.M., Jarvis W.R., Soucie J.M., Edwards J.E., Patterson J.E., Pfaller M.A., et al. Risk factors for candidal bloodstream infections in surgical intensive care units patients: the NEMIS prospective multicenter study. Clin Infect Dis 2001, 177-186.
8. Borzotta A.P., Beardsley K. Candida infections in critically ill trauma patients. Arch Surg 1999, 657-665.
9. Bross J., Talbot G.H., Maislin G., Hurwitz S., Strom B.L. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med 1989, 614-620.
10. Chamilos G., Lionakis M.S., Lewis R.E., Lopez-Ribot J.L., Saville S.P., Albert N.D., et al. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis 2006, 1014-1022.
11. Cheng Y.R., Lin L.C., Young G.T., Liu C.E., Chen C.H., Tsay R.W. Risk factors for candidemia-related mortality at a medical center in central Taiwan. J Microbiol Immunol Infect 2006, 155-161.
12. Clark T.A., Slavinski S.A., Morgan J., Lott T., Arthington-Skaggs B.A., Brandt M.E., et al. Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital. J Clin Microbiol 2004, 4468-4472.
13. Diekema D.J., Messer R.J., Hollis R., Jones N., Pfaller M.A. Nosocomial candidemia: an ounce of prevention is better than a pound of cure. Infect Cont Hosp Epidemiol 2004, 624-626.
14. Fridkin S.K., Jarvis W.R. Epidemiology of nosocomial fungal infections. Clin Microb Rev 1996, 499-511.
15. Garey K.W., Rege M., Pai M.P., Bearden M.T. Time to initiaton of fluconazole therapy impacts mortality: institutional study. Clin Infect Dis 2006, 43:25-31.
16. Goffi L., Saba V., Ghiselli R., Necozione S., Mattei A., Carle F. Preoperative APACHE II and ASA Scores in patients having major general surgical operations: prognostic value and potential clinical applications. Eur J Surg 1999, 730-735.
17. Gudlaugsson O., Gillespie S., Lee K., Vande Berg J., Hu J., Messer S., et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003, 1172-1177.
18. Gürcüoĝlu E., Ener B., Akali{dotless}n H., Si{dotless}ni{dotless}rtaş M., Evci C., Akçaĝlar S., et al. Epidemiology of nosocomial candidemia in a university hospital: a 12-year study. Epidemiol Infect 2010, 138:1328-1335.
19. Hall W.H., Ramachandran R., Narayan S., Jani A.B., Vijayakumar S. An electronic application for rapidly calculating Charlson co-morbidity score. BMC Cancer 2004, 1-8.
20. Hazen K.C., Howell S.A. Candida, Cryptococcus, and other yeasts of medical importance. Manual of Clinical Microbiology. 2007, 1762-1788. ASM Pres, Washington, DC. E.J. Baron, M.L. Landry, J.H. Jorgensen, M.A. Pfaller (Eds.).
21. Horan T.C., Gaynes R.P. Surveillance of nosocomial infections. Hospital Epidemiology and Infection Control. 2004, 1659-1702. Lippincott Williams & Wilkins, Philadelphia. C.G. Mayhall (Ed.).
22. Jorda-Marcos R., Alvarez-Lerma F., Jurado M., Palomar M., Nolla-Salas J., Leon C. Risk factors for candidemia in critically ill patients: a prospective surveillance study. Mycoses 2007, 302-310. EPCAN Study Group.
23. Labelle A.J., Micek S.T., Roubinian N., Kollef M.H. Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med 2008, 2967-2972.
24. Lagrou K., Verhaegen J., Peetermans W.E., Rijdt T.D., Maertens J., Wijngaerden E.V. Fungemia at a tertiary care hospital: incidence, therapy, distribution and antifungal susceptibility of causative species. Eur J Clin Microbiol Infect Dis 2007, 541-547.
25. Leon C., Alvarez-Lerma F., Ruiz-Santana S., Leon M.A., Nolla J., Jorda R., et al. Fungal colonization and/orinfection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis 2009, 233-242.
26. McMullan R., Metwally L., Coyle P.V., Hadderwick S., McCloskey B., O'Neill H.J., et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 2008, 39:890-896.
27. Meyer M.H., Letscher-Bru V., Jaulhac B., Waller J., Candolfi E. Comparison of mycosis IC/F and plus aerobic/F media for diagnosis of fungemia by the bactec 9240 system. J Clin Microbiol 2004, 42:773-777.
28. Morrell M., Fraser V.J., Kollef M.H. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005, 49:3640-3645.
29. Odabaşi{dotless} Z., Mattiuzzi G., Estey Elihu, Kantarjian H., Saeki F., Ridge R.J., et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cut-off development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004, 199-205.
30. Pappas P.G., Rex J.H., Lee J., Hamill R.J., Larsen R.A., Powderly W., et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003, 634-643.
31. Pappas P.G., Kauffman C.A., Andes D., Benjamin D.K., Calandra T.F., Edwards J.E., et al. Clinical practice guidelines for the management of Candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 503-535.
32. Pappo I., Polacheck I., Zmora O., Feigin E., Freund H.R. Altered gut barrier function to Candida during parenteral nutrition. Nutrition 1994, 151-154.
33. Parkins M.D., Sabuda D.M., Elsayed S., Laupland K.B. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 2007, 613-618.
34. Pfaller M.A., Pappas P.G., Wingard J.R. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis 2006, 3-14.
35. Pfaller M.A., Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007, 133-163.
36. Puzniak L., Teutsch S., Powderly W., Polish L. Has the epidemiology of nosocomial candidemia changed?. Infect Control Hosp Epidemiol 2004, 628-633.
37. Safdar A., Perlin D.S., Armstrong D. Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades. Diagn Microbiol Infect Dis 2002, 11-16.
38. Tattevin P., Chevrier S., Gangneux J.P. Can we describe the epidemiology of candidemia without using selective blood culture bottles for fungus detection?. Clin Infect Dis 2004, 39:598-599.
39. Tortorano A.M., Peman J., Bernhardt H., Klingspor L., Kibbler C.C., Faure O., et al. Epidemiology of candidemia in Europe: resuts of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004, 317-322.
40. Viudes A., Peman J., Canton E., Ubeda P. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis 2002, 767-774.
41. Wey S.B., Mori M., Pfaller M.A., Woolson R.F., Wenzel R.P. Hospital acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1998, 2642-2645.
42. Yapar N., Uysal U., Yucesoy M., Cakir C., Yuce A. Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital. Mycoses 2005, 134-138.